NCT04783857View on ClinicalTrials.gov

Modifying Progesterone and Estradiol Levels to Prevent Postpartum Cigarette Smoking Relapse and Reduce Secondhand Smoke Exposure in Infants and Children

PHASE4RecruitingINTERVENTIONAL
Enrollment

279

Participants

Timeline

Start Date

April 14, 2022

Primary Completion Date

June 2, 2026

Study Completion Date

June 2, 2026

Conditions
SmokingSmoking CessationSmoking Reduction
Interventions
DRUG

Progesterone 200 MG Oral Capsule

Progesterone, 200mg, once daily, oral tablet/capsule

Trial Locations (1)

55455

RECRUITING

University of Minnesota, Minneapolis

All Listed Sponsors
collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

University of Minnesota

OTHER